Mizkan Holdings Co., Ltd.赞助的临床试验
总计65个结果
-
Beijing Kawin Technology Share-Holding Co., Ltd.完全的
-
Beijing Kawin Technology Share-Holding Co., Ltd.完全的
-
Sihuan Pharmaceutical Holdings Group Ltd.Covance; XuanZhu Pharma Co., Ltd.完全的
-
Shanghai Pharmaceuticals Holding Co., LtdR&G Pharma Studies Co.,Ltd.完全的
-
Tongji UniversityShanghai Pharmaceuticals Holding Co., Ltd主动,不招人
-
Daiichi Sankyo, Inc.Daiichi Sankyo (China) Holdings Co., Ltd.主动,不招人
-
Resvent Holding USA LTDAvania; Resvent Medical Technology Co., Ltd.尚未招聘
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd尚未招聘
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd招聘中
-
Shanghai Jiaolian Drug Research and Development...Shanghai Pharmaceuticals Holding Co., Ltd招聘中
-
Tongji HospitalFujian Cosunter Pharmaceutical Co. Ltd; Beijing Kawin Technology Share-Holding Co., Ltd.完全的
-
Sun Yat-sen UniversityShanghai Pharmaceuticals Holding Co., Ltd未知
-
Shanghai EpimAb Biotherapeutics Co., Ltd.Labcorp Corporation of America Holdings, Inc招聘中
-
Shanghai EpimAb Biotherapeutics Co., Ltd.Labcorp Corporation of America Holdings, Inc尚未招聘转移性肺非小细胞癌 | IVA 期肺癌 AJCC v8 | IVB 期肺癌 AJCC v8 | III 期肺癌 AJCC v8 | IV 期肺癌 AJCC v8 | IIIA 期肺癌 AJCC v8 | IIIB 期肺癌 AJCC v8 | 晚期肺癌非小细胞癌 | EGFR突变相关肿瘤美国, 中国